ASLV-BASED VECTOR SYSTEM Russian patent published in 2015 - IPC C12N15/867 C12N7/01 A61K39/12 C12N7/04 

Abstract RU 2566563 C2

FIELD: medicine.

SUBSTANCE: invention relates to field of biotechnology, genetic engineering and virology. In addition to SIN-vector system contains besides first helper plasmid, intended for expression of viral fusion protein gag-pol, and second helper plasmid, intended for expression of envelope protein (env) of retrovirus. First and second helper plasmids, contained in packaging cell line or applied for its short-term transfection, serve for creation of non-replicating (RCR-incompetent) viral particles. Viral particles contain RNA, which contains on 3'-end SIN-LTR, claimed in invention, where RNA can have therapeutically effective segment, which, for instance, represents transgene. For this purpose extensive deletion of U3-region, which in the process of reverse transcription is copied in 5' LTR, is provided in 3'-SIN-LTR. In addition, all coding ASLV regions, as well as retroviral splicing donor sites are removed from SIN-vector. Invention can be applied in genetic therapy.

EFFECT: viral self-inactivating (SIN) vector, based on virus of sarcoma and avian leukaemia virus (ASLV), and cleaving-packaging system are described.

24 cl, 15 dwg, 2 tbl, 4 ex

Similar patents RU2566563C2

Title Year Author Number
VIRAL VECTORS WITH CONDITION-DEPENDENT REPLICATION AND THEIR USING 2001
  • Chang Jung-Nien
  • Lu Ksiaobin
  • Slepushkin Vladimir
  • Kound Betti
  • Dehvis Brajan
  • Ju Kviao
  • Jang Janping
  • Merling Rehndall
  • Khan Vej
  • Ni Jadzin
  • Li Juehksia
  • Dropulik Boro
RU2301260C2
MICROVESICLE AND METHOD FOR ITS PREPARATION 2014
  • Li Chzhun
  • Katsura Misako
  • Fen Lo
RU2693088C2
RETROVIRAL VECTOR BASED ON MURINE LEUKOSIS VIRUS (MLV) (VERSIONS) 1999
  • Kim Sunijoung
  • Ju Seung Sin
  • Kim Dzong-Mook
RU2203321C2
BIOPRODUCTION OF LENTIVIRAL VECTORS 2016
  • Lee, Chi-Lin
  • Bartlett, Jeffrey S.
RU2729385C2
IMPROVING GENETIC CONSTRUCTS FOR PROVIDING HIGH EFFICACY OF ANTI-HIV THERAPY 2013
  • Glazkova Dina Viktorovna
  • Bogoslovskaja Elena Vladimirovna
  • Markelov Mikhail Leonidovich
  • Shipulin German Aleksandrovich
  • Pokrovskij Valentin Ivanovich
  • Pokrovskij Vadim Valentinovich
RU2533817C1
AUXILIARY PLASMID LENTIVIRAL EXPRESSION VECTOR FOR OBTAINING HIGH TITERS OF Vpx-CONTAINING LENTIVIRAL PARTICLES, WHICH PROVIDES EFFECTIVE INFECTION OF HUMAN MONOCYTES AND DENDRITIC CELLS 2017
  • Chumakov Stepan Petrovich
  • Kravchenko Yuliya Evgenevna
  • Ivanova Anna Evgenevna
  • Frolova Elena Ivanovna
RU2697781C2
RECOMBINANT LENTIVIRAL VECTOR, HOST CELL TRANSDUCED WITH LENTIVIRAL VECTOR, METHODS FOR TRANSDUCTION AND USES THEREOF 2002
  • Trono Did'E
  • Viznerovich Matsej
RU2305708C2
GENETIC MAKE-UPS FOR ANTI-HIV THERAPY 2010
  • Glazkova Dina Viktorovna
  • Vetchinova Anna Sergeevna
  • Bogoslovskaja Elena Vladimirovna
  • Markelov Mikhail Leonidovich
  • Shipulin German Aleksandrovich
  • Kuevda Dmitrij Aleksandrovich
  • Pokrovskij Valentin Ivanovich
  • Pokrovskij Vadim Valentinovich
RU2426788C1
RECESSIVE DIVIDING RETROVIRAL VECTOR (VARIANTS), METHOD FOR PRODUCTION THEREOF (VARIANTS), ISOLATED AND PURIFIED NUCLEIC ACID MOLECULE 1996
  • Drop'Julik Boro
  • Piza Paula M.
RU2270250C2
METHOD FOR TEMPORARY TRANSFECTION FOR PRODUCING RETROVIRUS 2016
  • Johnson, Sabine
  • Pallant, Celeste
  • Vamva, Eirini
  • Vink, Conrad
RU2749717C2

RU 2 566 563 C2

Authors

Aksel' Shambakh

Kristofer Baum

Julija Debora Zjurt

Dates

2015-10-27Published

2010-05-17Filed